Stocksigma LogoStocksigma Logo

Venmax Drugs Reports Strong Q2 FY27 Revenue and Net Profit Growth

Venmax Drugs & Pharmaceuticals reported a 300.6% YoY jump in revenue from operations to Rs 528.21 lakhs for the quarter ended 30th Sep'26, up from Rs

Venmax Drugs Reports Strong Q2 FY27 Revenue and Net Profit Growth

Venmax Drugs and Pharmaceuticals Ltd 路 Financial Result 路 12 Nov 2026, 9:41 pm

Venmax Drugs Reports Strong Q2 FY27 Revenue and Net Profit Growth Venmax Drugs & Pharmaceuticals reported a 300.6% YoY jump in revenue from operations to Rs 528.21 lakhs for the quarter ended 30th Sep'26, up from Rs 131.85 lakhs in the prior-year period and Rs 247.94 lakhs in the preceding quarter. Net profit surged 393% YoY to Rs 12.03 lakhs compared to Rs 2.44 lakhs in Q2 FY26. For H1 FY27, revenue reached Rs 776.15 lakhs with net profit at Rs 23.69 lakhs. Diluted EPS stood at Rs 0.08 for the quarter. Total debt was cleared to zero.

Original exchange filing (PDF)

More announcements from Venmax Drugs and Pharmaceuticals Ltd

All Venmax Drugs and Pharmaceuticals Ltd announcements